Swiss pharma giant Roche says its new antibiotic zosurabalpin will progress to phase 3 testing. It’s the first drug in its class since 1968. “Gram-negative bacteria” pose a huge threat to ...

But a new antibiotic from Swiss pharmaceutical company Roche could change the future of how we treat Gram-negative bacteria. Roche announced on Monday that its antibiotic zosurabalpin will enter ...

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first ...

One of the primary mechanisms of antibiotic resistance in gram-negative bacteria is the use of efflux pumps. These protein pumps are designed to remove hazardous compounds (such as antibiotics ...

Gram-negative bacteria have the ability to cause a lot of diseases in humans. They can reach almost all of the organ systems. Your doctor may need to try several antibiotics to beat the infection.

In it, the researchers describe how an imbalance in the three-part protein complex — MacAB-TolC—helps gram-negative bacteria resist antibiotics. The MacAB-TolC complex, known as a multidrug ...

"There is some evidence that antibiotic resistance reveals itself in other ways; for example, the morphology of Gram-negative ...

Gram-negative bacteria develop resistance to commonly prescribed antibiotics through ... Antibiotic treatment guidelines consistently recommended empiric therapy upon patient presentation ...

Gram-positive and gram-negative bacteria are distinct types of bacteria. Learn more here. ... It also outlines their differences, the infections they cause, and discusses antibiotic resistance.

First, gram-negative bacteria have a thin cell wall that is about 1.5 to 10 nanometers across, ... —Bacteria that switch antibiotic resistance on and off are going undetected.

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

Imported seafood is screened for contaminants but the process doesn't catch everything, especially antimicrobial resistance ...